Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc., a company listed on AIM, has successfully raised approximately £3.54 million through increased investor demand in its recent fundraising efforts. The company will issue around 50.5 million new shares, which will represent roughly 18.2% of its enlarged share capital, with trading expected to start on AIM around May 9, 2024. Additionally, investors will receive one warrant for every two shares purchased, exercisable within nine months.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
